Citrobacter is a genus of bacteria found in the intestine and the environment. Some members can cause opportunistic infections. A genus-level stool finding needs to be distinguished from a specific species causing illness in a normally sterile site.
On this page
Why the genus name is not a diagnosis
Citrobacter includes species such as C. freundii and C. koseri. The clinical significance of a finding depends on the organism, the specimen and the person’s circumstances. Public-health descriptions include intestinal carriage as well as opportunistic infections; they do not make every stool finding an infection. [1]
What GI-MAP measures
The report contains a Citrobacter group target and a separate Citrobacter freundii target. Read both according to their own labels. A high group result does not identify every species or prove that the C. freundii line should also be high. [2]
Three results that answer different questions
Check the specimen, collection date and exact organism label before comparing two reports. These examples describe different kinds of evidence.
- GI-MAP Citrobacter spp.: a group-level stool DNA target. It does not identify every species present, explain symptoms by itself or tell you which antibiotic would work.
- GI-MAP C. freundii: a separate species-specific stool target. It does not establish infection in urine, blood or another body site. [2]
- A clinical culture with susceptibility testing: describes an organism recovered from that specimen and its reported antibiotic susceptibility. A finding from another specimen or collection date may have a different meaning. [3]
For example, a Citrobacter finding in stool does not establish that Citrobacter is causing a urinary complaint. The useful next question is which assessment fits the symptoms. A stool number cannot replace evidence from the suspected infection site. [1]
What an autoimmune-associated category means
Placement in a report category does not establish autoimmune disease, identify its cause or predict future illness. A bacterial DNA count cannot diagnose rheumatoid arthritis, inflammatory bowel disease or another immune-mediated condition. Symptoms and established clinical assessments remain necessary.
Does a high Citrobacter result mean ESBL?
No. A high organism quantity is not an antibiotic-resistance finding. ESBL refers to enzymes that break down certain antibiotics. Bacteria with these mechanisms may cause infection or be carried without symptoms. Clinicians use the clinical picture and appropriate laboratory testing, including susceptibility testing, to evaluate a suspected resistant infection. [3]
If you also have a resistance or culture report, bring the complete report. Ask which specimen was tested, which organism or resistance marker was identified, and whether that result changes care. Do not infer ESBL production or bloodstream infection from the Citrobacter abundance line alone.
What helps with interpretation
Bring the full report, a timeline of symptoms, recent antibiotics and any relevant immune-system conditions. Ask: What diagnosis is being considered? Does this finding change a concrete care decision? Would another test answer that question better? If the report is unexpected, ask the ordering clinician or laboratory about the target and reference range before acting on it.
Common questions
Is Citrobacter the same as C. freundii?
C. freundii is one species within the genus. A genus-level result is broader.
Does a negative stool result exclude Citrobacter infection elsewhere?
No. It does not test every body site or replace assessment of a suspected infection.
How should I interpret Citrobacter spp. high in stool?
It means that the reported group target is above that laboratory’s comparison range. Interpret it alongside symptoms and the rest of the report. The high flag alone does not show which species is responsible, diagnose an autoimmune condition or establish a need for antibiotics.
Sources and review
Sources checked November 12, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- Public Health Agency of Canada: Citrobacter
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
- CDC: About ESBL-producing Enterobacterales
This article has been reviewed by Madison Ordway, FDN-P. For a correction or source question, contact Gi Map Test.